// you're reading...


ImmunoSigns expand collaboration with medical imaging partners

A large international research consortium aim in 2009 to send a proposal to National Institute of Health in USA for funding exploring IC2 ability for clinical medical imaging by immunoPET and immunoPAT.

Welcome to ImmunoSigns

ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.

The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.

Shopping Cart